Digital health case studyPharmaceutical

Building a Startup Bridge in APAC for HPV, Cervical Cancer and Immuno-Oncology

Client context: Global pharmaceutical, APAC innovation team

Strategic question

Which APAC Digital Health ventures can help us drive HPV awareness, cervical cancer action and immuno-oncology innovation?

Decision enabled

What the client could do next

Enabled the client to open structured partnership conversations with high-potential APAC startups and investors.

Approach

Using HealthTech Alpha and on-the-ground APAC expertise, we mapped the Digital Health landscape across 10 markets, curated a shortlist of startups and investors, and designed engagement events to catalyse direct partnership conversations.

Methodology

DefineClarified the strategic question, scope, decision owner and evaluation criteria.
MapIdentified relevant ventures, markets, competitors, partnerships and ecosystem signals.
AssessEvaluated maturity, traction, evidence, strategic fit and operational readiness.
DecideTranslated findings into a decision-ready shortlist, benchmark or recommendation.

Strategic interpretation

Moved the franchise from passive scouting to active ecosystem engagement with decision-ready partners.

Overview

Category

Stage

Total Funding

GGA Score

powered by